Screening For Gestational Diabetes Mellitus Selectively in a University Maternity Hospital
| dc.contributor.author | O’Malley, EG | |
| dc.contributor.author | O’Duill, M | |
| dc.contributor.author | McArdle, C | |
| dc.contributor.author | Kennedy, RAK | |
| dc.contributor.author | Reynolds, CM | |
| dc.contributor.author | Turner, MJ | |
| dc.date.accessioned | 2018-06-20T12:36:11Z | |
| dc.date.available | 2018-06-20T12:36:11Z | |
| dc.date.issued | 2018-06 | |
| dc.identifier.uri | http://hdl.handle.net/10147/623081 | |
| dc.description.abstract | Gestational diabetes mellitus (GDM) is one of the commonest complications of pregnancy. The prevalence varies depending, for example, on the diagnostic criteria, the screening test used, laboratory standards and the population studied. However, the prevalence is increasing globally due to the increasing levels of maternal obesity. The detection of GDM is important because there are clinical consequences. The woman has an increased risk of pre-eclampsia and of developing Type 2 diabetes mellitus (T2DM) in later life. Up to 70% of those women with GDM develop T2DM by 28 years after the affected pregnancy2. In a pregnancy complicated by GDM there is an increased risk of fetal macrosomia and polyhydramnios due to fetal hyperglycaemia3. This is associated with an increased risk of shoulder dystocia and caesarean delivery4. Neonatal hypoglycaemia may develop due to increased insulin production secondary to intrauterine hyperglycaemia. The offspring also have an increased risk in their childhood and adult life for the development of diabetes, obesity and metabolic syndrome5. | |
| dc.language.iso | en | en |
| dc.publisher | Irish Medical Journal | en |
| dc.subject | PREGNANCY | en |
| dc.subject | DIABETES MELLITUS | en |
| dc.subject.other | pre-eclampsia | en |
| dc.title | Screening For Gestational Diabetes Mellitus Selectively in a University Maternity Hospital | en |
| dc.type | Article | en |
| dc.description.funding | No funding | en |
| dc.description.province | Leinster | en |
| dc.description.peer-review | peer-review | en |
| html.description.abstract | Gestational diabetes mellitus (GDM) is one of the commonest complications of pregnancy. The prevalence varies depending, for example, on the diagnostic criteria, the screening test used, laboratory standards and the population studied. However, the prevalence is increasing globally due to the increasing levels of maternal obesity. The detection of GDM is important because there are clinical consequences. The woman has an increased risk of pre-eclampsia and of developing Type 2 diabetes mellitus (T2DM) in later life. Up to 70% of those women with GDM develop T2DM by 28 years after the affected pregnancy2. In a pregnancy complicated by GDM there is an increased risk of fetal macrosomia and polyhydramnios due to fetal hyperglycaemia3. This is associated with an increased risk of shoulder dystocia and caesarean delivery4. Neonatal hypoglycaemia may develop due to increased insulin production secondary to intrauterine hyperglycaemia. The offspring also have an increased risk in their childhood and adult life for the development of diabetes, obesity and metabolic syndrome5. |